Trials / Completed
CompletedNCT01489293
Inhibitory Receptors in Eosinophils of Atopic Subjects
Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-12-31
- Completion
- 2013-12-31
- First posted
- 2011-12-09
- Last updated
- 2018-03-22
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01489293. Inclusion in this directory is not an endorsement.